(Q44190214)

30 November 2017

title

Amisulpride does not prevent relapse in primary alcohol dependence: results of a pilot randomized, placebo-controlled trial (English)

1 reference

30 November 2017

1 reference

1 reference

Donata Marra

1

1 reference

30 November 2017

Dominique Warot

2

1 reference

30 November 2017

Ivan Berlin

3

1 reference

30 November 2017

Eric Hispard

4

1 reference

30 November 2017

Christine Notides

5

1 reference

30 November 2017

Samir Tilikete

6

1 reference

30 November 2017

Christine Payan

7

1 reference

30 November 2017

Jean-Pierre Lépine

8

1 reference

30 November 2017

Sylvain Dally

9

1 reference

30 November 2017

Henri-Jean Aubin

10

1 reference

30 November 2017

publication date

1 October 2002

1 reference

Alcoholism: Clinical and Experimental Research

30 November 2017

published in

1 reference

30 November 2017

volume

26

1 reference

30 November 2017

issue

10

1 reference

30 November 2017

page(s)

1545-1552

1 reference

Affective and anxiety disorders and alcohol and drug dependence: diagnosis and treatment

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02454.X

The obsessive compulsive drinking scale: A new method of assessing outcome in alcoholism treatment studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02454.X

Pharmacological treatment of alcohol dependence: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02454.X

Potentiation by low doses of selected neuroleptics of food-induced conditioned place preference in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02454.X

Drug abuse: hedonic homeostatic dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02454.X

Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02454.X

A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02454.X

Alcoholism and the dopaminergic system: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02454.X

Six-month follow-up of naltrexone and psychotherapy for alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02454.X

Craving and relapse measurement in alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02454.X

Lisuride, a dopamine D2 receptor agonist, and anticraving drug expectancy as modifiers of relapse in alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02454.X

The reliability of the Alcohol Timeline Followback when administered by telephone and by computer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02454.X

Naltrexone in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02454.X

Flupenthixol decanoate and relapse prevention in alcoholics: results from a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02454.X

10.1111/J.1530-0277.2002.TB02454.X

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference